| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/12/2013 | CN103142770A Compound houttuynia cordata lotion and preparation method thereof |
| 06/12/2013 | CN103142732A Traditional Chinese medicine composition for treating hypertension |
| 06/12/2013 | CN103142706A Application of perfoliote knotweed herb |
| 06/12/2013 | CN103142696A Vessel-invigorating and life-prolonging soup and preparation method thereof |
| 06/12/2013 | CN103142685A Method for extraction of total flavonoid aglycones from hickory leaves |
| 06/12/2013 | CN103142681A Flemingia philippinensis total flavonoids and beta-cyclodextrin clathrate compound and preparation method thereof |
| 06/12/2013 | CN103142680A Heart-nourishing and blood-circulation-promoting prescription |
| 06/12/2013 | CN103142678A Preparation method of radix pseudostellariae total glycosides and application thereof to preparation of medicament for preventing and treating myocardial anoxia and myocardial ischemia |
| 06/12/2013 | CN103142669A Enzyme method for extracting ginsenoside and obtained ginsenoside extractive |
| 06/12/2013 | CN103142662A Method for extracting and purifying polyphenol from choerospondias axillaris peel |
| 06/12/2013 | CN103142661A Preparation method of inonqqus obliquus water-extract fine powder |
| 06/12/2013 | CN103142660A Wood seed tannic acid treatment cream |
| 06/12/2013 | CN103142647A Lanthanum hydroxide therapeutical effects on hyperphosphatemia and relative diseases |
| 06/12/2013 | CN103142643A Autoimmune hemolytic anemia (ALHA) cardioplegic solution and preparation method thereof |
| 06/12/2013 | CN103142618A Metroprolol succinate hydrochlorothiazide sustained-release pellet capsule and preparation method thereof |
| 06/12/2013 | CN103142602A Application of allopurinol in preparing medicines after atrial fibrillation catheter ablation |
| 06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
| 06/12/2013 | CN103142596A Medicinal composition containing telmisartan and pitavastatin |
| 06/12/2013 | CN103142579A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
| 06/12/2013 | CN103142578A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
| 06/12/2013 | CN103142577A Salvianolic acid A composition and application thereof to medicine preparation |
| 06/12/2013 | CN103142576A Application of salvianolic acid A freeze-dried powder to preparation of drug for protecting cerebral vascular endothelial cells |
| 06/12/2013 | CN103142575A Application of salvianolic acid A freeze-dried powder to preparation of drug for inhibiting neuronal damage or death of brain tissue |
| 06/12/2013 | CN103142574A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
| 06/12/2013 | CN103142573A Application of salvianolic acid A freeze-dried powder to preparation of drug for improving symptom of neurological function after cerebral ischemia |
| 06/12/2013 | CN103142572A Salvianolic acid A tablet and application thereof to medicine preparation |
| 06/12/2013 | CN103142571A Salvianolic acid A composition and application thereof to medicine preparation |
| 06/12/2013 | CN103142569A 2, 6-diisopropyl benzoic acid and application of 2, 6-diisopropyl benzoic acid derivative serving as neuroprotective agent |
| 06/12/2013 | CN103142557A Polymannuronate sulfate slow release capsule and preparation method thereof |
| 06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142549A Mannose ester enteric capsule and preparation method thereof |
| 06/12/2013 | CN103142543A Salvianolic acid A capsule and application thereof to medicine preparation |
| 06/12/2013 | CN103142542A Salvianolic acid A capsule and application thereof to medicine preparation |
| 06/12/2013 | CN103142540A PGMS (Propylene Glycol Mannate Sulfate) controlled-release tablet and preparation method thereof |
| 06/12/2013 | CN103142539A Alginic sodium diester controlled-release tablet and preparation method thereof |
| 06/12/2013 | CN103142538A PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142535A Alginic sodium diester enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142532A Ginkgolide osmotic pump tablet and preparation method thereof |
| 06/12/2013 | CN103142531A Aspirin slow release tablet and preparation method thereof |
| 06/12/2013 | CN103142529A Indapamide sustained-release drug composite and preparation method thereof |
| 06/12/2013 | CN103142519A Levocarnitine tablets and preparation method thereof |
| 06/12/2013 | CN103142517A Salvianolic acid A dropping pill and application thereof to medicine preparation |
| 06/12/2013 | CN103142516A Salvianolic acid A dropping pill and application thereof to medicine preparation |
| 06/12/2013 | CN103142508A Application of salvianolic acid A freeze-dried powder to preparation of drug for protecting ischemia brain tissue damage |
| 06/12/2013 | CN103142504A PGMS (Propylene Glycol Mannate Sulfate) sustained-release granule and preparation method thereof |
| 06/12/2013 | CN103142490A Nesiritide acetate sustained-release microsphere preparation and preparation method thereof |
| 06/12/2013 | CN103142489A Human alpha-atrial natriuretic peptide sustained release microsphere preparation and preparation method thereof |
| 06/12/2013 | CN103142474A Composition taking high-purity ginkgolide B as active ingredient and preparation method thereof |
| 06/12/2013 | CN103142473A Composition containing high purity bilobalide B and preparation method thereof |
| 06/12/2013 | CN103142472A Ginkgolide B composition and preparation method thereof |
| 06/12/2013 | CN103142464A Ligustrazine hydrochloride or tetramethylpyrazine phosphate transdermal delivery preparation |
| 06/12/2013 | CN103141934A Agilawood civet coffee cigarette and preparation method thereof |
| 06/12/2013 | CN102652755B Mannitol sodium chloride injection and preparation method thereof |
| 06/12/2013 | CN102640829B Tea paste with myocardial ischemia function improving function and preparation method of tea paste |
| 06/12/2013 | CN102614436B Chinese medicinal preparation for treating pulmonary heart disease and preparation method for Chinese medicinal preparation |
| 06/12/2013 | CN102614435B Chinese medicinal aerosol for treating acute attack of pulmonary heart disease and preparation method thereof |
| 06/12/2013 | CN102600228B Method for preparing gypenoside in gypenoside grains |
| 06/12/2013 | CN102579503B Method for separating skin of eupolyphaga egg clamp from egg inside eupolyphaga egg clamp |
| 06/12/2013 | CN102512614B Bath lotion for treating inflammatory external hemorrhoid |
| 06/12/2013 | CN102441156B Traditional Tibetan medicinal composition and preparation method thereof |
| 06/12/2013 | CN102429932B Method for extracting lucid ganoderma essence |
| 06/12/2013 | CN102379843B Levocarnitine pharmaceutical composition for injection |
| 06/12/2013 | CN102370896B Medicine for treating cerebral thrombosis |
| 06/12/2013 | CN102309632B Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 06/12/2013 | CN102293791B Production method for extracting effective components of gingko leaf |
| 06/12/2013 | CN102258736B Mongolian medicine for treating local circulatory disturbance |
| 06/12/2013 | CN102258587B Preparation method and application of red paeony root active ingredient |
| 06/12/2013 | CN102225107B Yixin xuezhikang capsule |
| 06/12/2013 | CN102190706B Loach protein antihypertensive peptide and preparation method thereof |
| 06/12/2013 | CN102188664B Method for preparing compound musk injection |
| 06/12/2013 | CN102188520B Traditional Chinese medicine composition for the treatment of cerebral ischemia and application thereof |
| 06/12/2013 | CN102133333B Quality control method for shenmai injection mass spectrum finger prints |
| 06/12/2013 | CN102101880B Preparation method and application of radix astragali saponin |
| 06/12/2013 | CN102093353B 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 06/12/2013 | CN102067998B Health care additive for reducing neck and shoulder pain, neck ache symptoms and improving sleep |
| 06/12/2013 | CN102058830B Medicinal composition preparation and preparation method thereof |
| 06/12/2013 | CN102007133B 3-phenylpyrazolo[5,1-b]thiazole compounds |
| 06/12/2013 | CN101914135B Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof |
| 06/12/2013 | CN101906054B N-(3,4-dyhydroxy benzoyl)-3,4-dyhydroxy benzamide and preparation method and application thereof |
| 06/12/2013 | CN101780140B Drug for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 06/12/2013 | CN101721456B Antiatherosclerotic Chinese traditional medicine for treating cardiovascular and cerebrovascular diseases and method for preparing phospholipid complex formulation thereof |
| 06/12/2013 | CN101641089B An extract |
| 06/12/2013 | CN101600683B Therapeutic compounds |
| 06/12/2013 | CN101594861B Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 06/12/2013 | CN101594782B Oil-and-fat composition, and food or beverage containing the oil-and-fat composition |
| 06/12/2013 | CN101522631B Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ss2 adrenergic receptor |
| 06/12/2013 | CN101507749B Medicine composition for curing the cerebrovascular disease |
| 06/12/2013 | CN101429184B Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 06/12/2013 | CN101410370B Selective hydroxamate based MMP inhibitors |
| 06/12/2013 | CN101380379B Total flavone in leaves of Murraya paniculata (L.) Jack and preparation method and use thereof |
| 06/12/2013 | CN101352433B Formulation capable of effectively balancing blood pressure, blood fat and promoting cardio-cerebral arterial vascular softening, and preparation method thereof |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | US8461165 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 06/11/2013 | US8461151 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
| 06/11/2013 | US8460931 Neural progenitor cells derived from embryonic stem cells |
| 06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2706357C 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease |
| 06/11/2013 | CA2601427C A method and composition for nutritionally improving glucose control and insulin action |